4Suppliers
4Customers
3Debt Items
20Related Chains

Source-Backed Evidence Depth

Daré Bioscience, Inc. (DARE) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

12Total relationships
3Distinct source URLs
6High confidence
0.803Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Daré Bioscience, Inc. Suppliers

TickerNameConfidenceEvidence
SECTION-503B-REGISTERED-OUTSOURCING-FACILITIES SECTION-503B-REGISTERED-OUTSOURCING-FACILITIES 90% the Company makes unsecured advances to certain suppliers, specifically, the Section 503B-registered outsourcing facilities engaged to manufacture and distribute the Company's Section 503B products
ORANY ORANY 72% her material deficiency is found. The FDA requires that certain classifications of recalls be reported to the FDA within ten working days after the recall is initiated. As with prescription drugs, th…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from DARE graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from DARE graph: her material deficiency is found.…
XOMA XOMA Royalty Corporation 72% Reciprocal relationship from XOMA graph: Item 4. ​ Mine Safety Disclosures ​ 70 ​ ​ ​ ​ ​ Item 5. ​ Other Information ​ 70 ​ ​ ​ ​ ​ Item 6. ​ Exhibits ​ 71 ​ ​ ​ ​ ​ Signatures ​ 74 ​ ​ ​ 2 Table of…

Daré Bioscience, Inc. Customers

TickerNameConfidenceEvidence
GATES-FOUNDATION GATES-FOUNDATION 92% The Foundation Services Agreements are accounted for as contracts with a customer under FASB Accounting Standards Codification (ASC) 606, as each represents an exchange transaction in which the Found…
ORANY ORANY 72% her material deficiency is found. The FDA requires that certain classifications of recalls be reported to the FDA within ten working days after the recall is initiated. As with prescription drugs, th…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from DARE graph: her material deficiency is found. The FDA requires that certain classifications of recalls be reported to the FDA wi…
DARE-MB-INC DARE-MB-INC 62% . The Foundation Services Agreements are accounted for as contracts with a customer under FASB Accounting Standards Codification ("ASC") 606, as each represents an exchange transaction in which the F…

Daré Bioscience, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
DARE-DEBT-9017 Warrants outstanding: 265485 90% xbrl warrant detail from xbrl 2023-12-31.
DARE-DEBT-9018 Xbrl Convertible 90% xbrl convertible detail from xbrl 2018-12-31.
DARE-DEBT Debt stack $10,542 90% Market cache reports total debt of $10,542.

Daré Bioscience, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Daré Bioscience, Inc..

Daré Bioscience, Inc. Ownership

HolderNameConfidenceEvidence
DARE-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 26 tracked holders.

Daré Bioscience, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
XOMA XOMA Royalty Corporation 100.00 1 ['supplier']
ORANY ORANGE 100.00 1 ['customer', 'supplier']
BCDRF Banco Santander, S.A. 50.00 2
BLTE Belite Bio, Inc 50.00 2
ASBPW Aspire Biopharma Holdings, Inc. 50.00 2
BFRGW BullFrog AI Holdings, Inc. 50.00 2
BFRIW Biofrontera Inc. 50.00 2
CINGW Cingulate Inc. 50.00 2
AMZE Amaze Holdings, Inc. 50.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
ARQQW Arqit Quantum Inc. 50.00 2
AYTU Aytu BioPharma, Inc. 50.00 2
CYCN Cyclerion Therapeutics, Inc. 50.00 2
CMCM Cheetah Mobile Inc. 50.00 2
D Dominion Energy, Inc. 50.00 2
AMXOF AMERICA MOVIL SAB DE CV/ 50.00 2
EPDU ENTERPRISE PRODUCTS PARTNERS L.P. 50.00 2
CYTOF Altamira Therapeutics Ltd. 50.00 2
CANF Can-Fite BioPharma Ltd. 50.00 2
BDRX Biodexa Pharmaceuticals Plc 50.00 2
🔐
DARE
Unlock DARE Supply Chain Data
Verified relationships include:
SECTION-503B-REGISTERED-OUTSOURCING-FACILITIESSECTION-503B-REGISTERED-O…Supplier90%
ORANYORANYSupplier72%
GATES-FOUNDATIONGATES-FOUNDATIONCustomer92%
ORANYORANYCustomer72%
+8 more relationships locked
Subscribe, View plans →